PEAK6’s NeoGenomics NEO Stock Holding History

PEAK6’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,691	Closed	-$188K	–	3296
2025 Q2	$188K	Buy	25,691 +9,815	+62%	+$79.2K	﹤0.01%	2473
2025 Q1	$151K	Buy	+15,876	New	+$198K	﹤0.01%	2516

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

PEAK6's NEO Position: Q3 2025 in Review

PEAK6 sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 25,691 shares — an estimated $188K sold.

PEAK6 first reported a position in NEO in Q1 2025 and held it in 2 quarters. The position peaked at $188K in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

PEAK6 reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
PEAK6 sold 25,691 NeoGenomics shares in Q3 2025, an estimated $188K.
PEAK6 first reported a position in NeoGenomics in Q1 2025 and held it in 2 quarters.
PEAK6's NeoGenomics position peaked at $188K in Q2 2025.
254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on PEAK6's 13F filing for Q3 2025, filed 14 Nov 2025.